Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2001
09/26/2001CN1314881A Imidamide derivatives
09/26/2001CN1314827A Multilayered shell catalyst for catalytic gaseous phase oxidation of aromatic hydrocarbons
09/26/2001CN1071746C Amidine derivatives with nitric oxide synthetase activities
09/25/2001US6294678 Treatment for cancer and compounds for use therewith
09/25/2001US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors
09/25/2001US6294574 Compounds and methods for the treatment of inflammatory and immune disorders
09/25/2001US6294573 Reverse hydroxamate inhibitors of matrix metalloproteinases
09/25/2001US6294504 Antidotes for herbicides
09/25/2001CA2213404C Use of angiogenesis suppressors for inhibiting hair growth
09/20/2001WO2001068654A2 Tubulin binding ligands and corresponding prodrug constructs
09/20/2001WO2001068632A1 Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
09/20/2001WO2001068631A1 Method for the preparation of citalopram
09/20/2001WO2001068630A1 Method for the preparation of citalopram
09/20/2001WO2001068629A1 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
09/20/2001WO2001068628A1 Method for the preparation of citalopram
09/20/2001WO2001068627A1 Crystalline base of citalopram
09/20/2001WO2001068626A1 Method for producing maleic acid anhydride
09/20/2001WO2001068625A1 Method for the production of spirocyclic tetronic acid derivatives
09/20/2001WO2001068619A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001WO2001068591A1 Carboxylic acid derivatives as ip antagonists
09/20/2001WO2001068245A1 Hollow cylindrical catalyst and a method for producing a maleic acid anhydride
09/20/2001WO2001068084A1 Il-8 receptor antagonists
09/20/2001WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
09/20/2001DE10013167A1 Cosmetic or dermatological skin treatment composition containing ascorbic acid or derivative, stabilized by combination of polyphenol, lipophilic antioxidant and basic nitrogen compound
09/20/2001CA2411732A1 Crystalline base of citalopram
09/20/2001CA2403062A1 Il-8 receptor antagonists
09/20/2001CA2403017A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001CA2402869A1 Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
09/20/2001CA2402557A1 Method for the preparation of citalopram
09/20/2001CA2402553A1 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
09/20/2001CA2402420A1 Method for producing maleic acid anhydride
09/20/2001CA2402388A1 Method for the preparation of citalopram
09/20/2001CA2402386A1 Method for the preparation of citalopram
09/19/2001EP1134217A2 Cosmetic composition containing a furan-naphthoquinone derivative, use therof as dyeing agent, and derivatives
09/19/2001EP1134216A1 Anti-drug resistant strain agents and antichlamydia agents
09/19/2001EP1133493A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
09/19/2001EP1133491A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
09/19/2001EP1133486A2 Nonsteroidal antiinflammatories
09/19/2001EP1015416B1 Method for the preparation of citalopram
09/19/2001EP0912488B1 Process for the production of 1,4-butanediol, gamma-butyrolactone and tetrahydrofuran
09/19/2001EP0889901B1 Process and intermediates for the synthesis of lhrh antagonists
09/19/2001EP0638077B1 Chiral cyclopentene derivatives and their preparation
09/19/2001EP0612244B1 Endothelin receptor antagonists
09/19/2001CN1313857A Methods for synthesis of substituted tetrahydrofuran compound
09/19/2001CN1313850A New unsaturated oxime derivatives and the use thereof as latent acids
09/19/2001CN1313284A N-(3-benzofuryl) urea derivative
09/19/2001CN1313283A Intermediate for preparing substituted dioxazine
09/19/2001CN1313282A Process for treating waste water containing furaldehyde and recovering furaldehyde and acetic acid
09/19/2001CN1071325C Thiol derivatives with metallopeptidase inhibitory activity
09/19/2001CN1071303C Phosgenation under pressure of acids and/or anhydrides for production of acid chlorides
09/18/2001US6291689 Cyclizing 4-cyano-2-hydroxymethylphenyl)(4-fluorophenyl)methanol to form 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; alkylating to form citalopram
09/18/2001US6291688 Processes for preparing 2-(omega-alkoxycarbonylalkanoyl)-4- butanolides omega-hydroxy-(omega-3)-keto fatty esters, and derivatives thereof
09/18/2001US6291530 Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity
09/18/2001US6291520 Hydroxamic acid and N-hydroxyurea derivatives and their use
09/18/2001US6291500 Administering an antifungal agent
09/18/2001US6291464 Aminopiperazine derivatives
09/18/2001US6291400 Herbicidal compounds
09/18/2001US6291399 Agent for controlling diseases and insect pests, containing alkoxyimino-substituted bicyclic derivative as active ingredient
09/18/2001US6289892 Partial liquid breathing of fluorocarbons
09/17/2001CA2341840A1 Cosmetic composition comprising a furan-naphthoquinone derivative, its use as a coloring agent and derivatives
09/13/2001WO2001066536A1 Process for the preparation of citalopram
09/13/2001WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists
09/13/2001WO2001066501A1 Process for the preparation of organic compounds with manganese catalysts or the like
09/13/2001WO2001018231A3 METHOD FOR PRODUCING (R) OR (S)-HYDROXY-η-BUTYROLACTONE
09/13/2001WO2001012615A3 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives
09/13/2001US20010021781 Catalyst for hydrogenating dicarboxylic acids
09/13/2001US20010021775 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa
09/13/2001US20010021715 Gastrointestinal disorders
09/13/2001DE10011309A1 Production of maleic anhydride comprises gas-phase oxidation of hydrocarbons in a reactor comprising at least two sequential cooled reaction zones at different temperatures
09/13/2001DE10011307A1 Vanadium-phosphorus-oxygen catalyst for maleic anhydride production by gas-phase oxidation of hydrocarbons, in the form of hollow cylinders with defined dimensions
09/13/2001CA2401861A1 Process for the preparation of citalopram
09/12/2001EP1132383A1 Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
09/12/2001EP1131674A1 Colour photographic material
09/12/2001EP1131061A1 Agent for lowering prolactin
09/12/2001EP1049688B1 Process for the production of 2,5-dihydrofuran
09/12/2001EP0891354B1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands
09/12/2001CN1312800A Therapeutic biaryl derivatives
09/12/2001CN1070841C Carboxylic acid derivatives, their preparation and their use
09/11/2001US6288278 Benzene derived amino alcohols as drugs
09/11/2001US6288272 Reaction of enantiomorphs of amylopectin to linked oligosaccharide, oxidation of oligosaccharide, esterification with alcohol
09/11/2001US6288245 Hydrogenation of maleic anhydride, succinic anhydride and/or fumaric acid esters with copper catalyst
09/11/2001US6288244 Process for the preparation of 3, 4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars
09/11/2001US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
09/11/2001US6288106 Administering a metal-alpha-lipoic acid as a hypotensive agent, antidiabetic agents and vasoconstrictors, and to treat vision defects, alzheimer*s disease, parkinson*s disease, cardiovascular disorders and brain disorders
09/11/2001US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/11/2001US6288085 Piperidine derivatives for treating psychoses
09/11/2001US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents
09/11/2001US6288058 Treating muscular, nervous system, psychological and gastrointestinal disorders
09/11/2001CA2057578C 1,4-disubstituted piperazines, process for their preparation and pharmaceutical compositions containing them
09/11/2001CA2031570C Substituted cyclohexenes as central nervous system agents
09/07/2001WO2001064676A2 INHIBITORS OF p38-α KINASE
09/07/2001WO2001064662A1 Allomorph isomer z hydrochloride of ranitidine
09/07/2001WO2001064646A2 Hydrazones and analogs as cholesterol lowering agents
09/07/2001WO2001064637A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
09/07/2001WO2001055111A8 Biaryl compounds, their preparation and their use in therapy
09/07/2001WO2001021607A3 Process for the preparation of mycophenolic acid and derivatives thereof
09/07/2001WO2001010383A3 Caspase inhibitors and uses thereof
09/06/2001US20010020021 Metalloprotease inhibitor
09/06/2001US20010020013 Polymerase inhibitors
09/06/2001US20010019837 Process for microbially oxidizing n-substituted glucamines